ARNA Panacea Genomics is an innovative biotechnology company, launched by a team of scientists and entrepreneurs who are similarly minded and grew from scientific research and laboratory to full-scale business. ARNA developed a revolutionary method of early detection of specific cancers to launch a series of diagnostic tests for early detection of cancer in the global marketplace.
ARNA Panacea is the solution given to all participants who are interested in the diagnosis of cancer in the market in a new way to access. and interact with systems to collect and store data for medical research. By using the ARNA token, the holder will be able to access their medical and service data storage services for use in professional medical purposes, and to raise funds to start new research.
MISSION
Increase life expectancy and reduce human death. ARNA relentlessly pursues this goal through sophisticated screening methods, diagnostic corrections, treatments, monitoring and improved patient compliance.
INNOVATION
ARNA Genomics has found a technology that allows the development of very specific tests for different cancers. In addition, the company has also developed a unique concept of a platform-based platform ecosystem blockchain intended to be used as a tool to support the implementation of biotechnology and R & D worldwide.
ARNA Genomics has completed its first product for ARS R & D-test breast cancer. Colon cancer tests are at the R & D stage. ARNA devotes all of our resources to complement the development of the ARNA Elixir-blockchain platform, which will hope to change the world by making the launch of new biotech treatment solutions and fighting cancer much easier, cheaper and more fast.
The development of the ARNA effectual
ARNA Genomics will give all market participants working with cancer a fundamental new way to access and interact with data collection and storage of clinical trials environment. Using a token ARNA holder will be able to pay service members on other systems (eg cancer checks, tests, etc.), Gain access to data storage systems for medical experiments for the use of medical professionals, pay for other service users. system or start fundraising for a new study.
In collaboration with the FDA regulator (our Food and Drug Administration), the ARNA genomics will test the appropriate data storage system to gather an evolutionary base to be used by regulators to gain more product licensing (ARNA BC breast cancer detection) opportunities into the US mass market. The ARNA genomics will use the existing methodology and "best practices" for successful development and implementation of this solution to all Panacea ARNA ecosystem members:
Discuss and discover: the first phase of the project will include discussion and evaluation of key market players in terms of adaptation of Blockchain technology, as well as all technical requirements.
Prototype design: this phase & deals with the development of the Blockchain node prototype with a trusted partner to evaluate and conduct a thorough ARNA efficacy test.
Development: the development of the model base system will be completed during this phase.
Usage: this stage involves the use of the mangosteen ecosystem as well as the involvement of new ARNA partners and market participants.
Application Support: ARNA Genomics will continue to support the system and its members for a limited period of time.
CONCEPT
The Panacea ARNA concept is a solution that gives all participants interested in the cancer diagnostics market in a new way to access and interact with systems to collect and store data for medical research. By using the ARNA token, the holder will be able to access their service data storage and medical research for use in professional medical purposes, and to raise funds to start new research.
ARNA TEAM
Egor Melnikov - Founder & CEO
George Nikitin - COO & founder
Anatoliy Melnikov - Scientific inspector and creator of the ARNA BC test
Ilya Senechkin - PhD, Wageningen University, Netherlands
Sergey Chernyshev - Ph.D., molecular biotechnology expert
Magomed Chatuev - Architects and software developers
Sergey Dolgachev - Entrepreneurs and co-owners
FOR FURTHER INFORMATION, PLEASE VISIT LINKS BELOW:
Author: han emily
ETH Address: 0x32412715249f0c79b4fb958c6E32D871EaC778D2
Komentar
Posting Komentar